- Home
- ATAI vs HYLN Comparison
ATAI vs HYLN Comparison
Compare ATAI & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- HYLN
- Stock Information
- Founded
- ATAI 2018
- HYLN 2018
- Country
- ATAI Germany
- HYLN United States
- Employees
- ATAI N/A
- HYLN N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- HYLN Construction/Ag Equipment/Trucks
- Sector
- ATAI Health Care
- HYLN Consumer Discretionary
- Exchange
- ATAI Nasdaq
- HYLN Nasdaq
- Market Cap
- ATAI 291.5M
- HYLN 279.7M
- IPO Year
- ATAI 2021
- HYLN N/A
- Fundamental
- Price
- ATAI $1.24
- HYLN $1.41
- Analyst Decision
- ATAI Strong Buy
- HYLN Hold
- Analyst Count
- ATAI 4
- HYLN 1
- Target Price
- ATAI $9.00
- HYLN $2.00
- AVG Volume (30 Days)
- ATAI 1.7M
- HYLN 1.0M
- Earning Date
- ATAI 03-17-2025
- HYLN 04-29-2025
- Dividend Yield
- ATAI N/A
- HYLN N/A
- EPS Growth
- ATAI N/A
- HYLN N/A
- EPS
- ATAI N/A
- HYLN N/A
- Revenue
- ATAI $308,000.00
- HYLN $1,509,000.00
- Revenue This Year
- ATAI N/A
- HYLN $1,360.04
- Revenue Next Year
- ATAI $20.00
- HYLN $64.35
- P/E Ratio
- ATAI N/A
- HYLN N/A
- Revenue Growth
- ATAI N/A
- HYLN 124.55
- 52 Week Low
- ATAI $1.03
- HYLN $1.21
- 52 Week High
- ATAI $2.85
- HYLN $4.10
- Technical
- Relative Strength Index (RSI)
- ATAI 36.74
- HYLN 33.69
- Support Level
- ATAI $1.42
- HYLN $1.34
- Resistance Level
- ATAI $1.58
- HYLN $1.68
- Average True Range (ATR)
- ATAI 0.12
- HYLN 0.10
- MACD
- ATAI -0.00
- HYLN 0.00
- Stochastic Oscillator
- ATAI 4.55
- HYLN 20.00
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.